<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NovaBone Putty &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/novabone-putty/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Tue, 12 Aug 2025 04:43:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>NovaBone Putty &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>NovaBone Secures FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications</title>
		<link>https://innovate.research.ufl.edu/novabone-putty-fda-clearance/</link>
		
		<dc:creator><![CDATA[sooyoungryu]]></dc:creator>
		<pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[Tech Licensing]]></category>
		<category><![CDATA[UF Innovate]]></category>
		<category><![CDATA[UF Startup]]></category>
		<category><![CDATA[fda clearance]]></category>
		<category><![CDATA[NovaBone]]></category>
		<category><![CDATA[Novabone Products]]></category>
		<category><![CDATA[NovaBone Putty]]></category>
		<category><![CDATA[UF startup]]></category>
		<guid isPermaLink="false">https://scaddev1.com/novabone-putty-fda-clearance/</guid>

					<description><![CDATA[UF Startup NovaBone Products announced that it has received FDA clearance for its bioactive synthetic bone graft, NovaBone Putty, which is now expandable for use in the intervertebral disc space.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">NovaBone Products, a UF Startup and a leader in synthetic bone graft solutions, has announced its latest milestone: FDA clearance for its bioactive synthetic bone graft, NovaBone Putty, now expanded for use in the intervertebral disc space. This clearance marks an important addition to NovaBone’s existing portfolio, extending the use of NovaBone Putty for interbody fusion procedures to support a broader range of spinal and orthopedic surgical needs.</p>



Read more about <a href="https://www.entrepreneurshipreporter.com/article/759924959-novabone-secures-fda-clearance-for-expanded-indications-of-putty-in-interbody-fusion-applications"> NovaBone Secures FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications.</a>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
